))
Episode 18 - Issues with Treatments
Manage episode 413818591 series 3506573
Konten disediakan oleh Debbie and Elyse. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Debbie and Elyse atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
In this episode, we’re talking about some issues with treatments. We’re looking at some drugs that have lost or might lose their approvals, or cases where additional measures are put in place for safety reasons.
Here are some resources or references used in the research for this episode -
Crizanlizumab statement. January 2024 » Sickle Cell Society
Crizanlizumab - end of NHS supply » Sickle Cell Society
FDA starts speedy review of Novartis’ sickle cell antibody - PMLiVE
Exa-Cel (Casgevy) Gene Therapy Update » Sickle Cell Society
Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions - GOV.UK (www.gov.uk)
Remember, you can get in touch with us via clinical.research.intro@gmail.com. Please feel free to send questions, comments and compliments for Elyse to read out on the pod. It’s fun to make Debbie squirm!
Credit to our friend Sam Winnie for their awesome and cute music. Check out their work at https://www.samwinnie.com/
27 episode
Bagikan
